Novartis AG (MEX:NVS N) Beginning Cash Position : MXN234,431 Mil (As of Mar. 2025)

View and export this data going back to 2008. Start your Free Trial

What is Novartis AG Beginning Cash Position?

Novartis AG's Beginning Cash Position for the quarter that ended in Mar. 2025 was MXN234,431 Mil.

Novartis AG's quarterly Beginning Cash Position increased from Sep. 2024 (MXN155,612 Mil) to Dec. 2024 (MXN283,825 Mil) but then declined from Dec. 2024 (MXN283,825 Mil) to Mar. 2025 (MXN234,431 Mil).

Novartis AG's annual Beginning Cash Position declined from Dec. 2022 (MXN241,887 Mil) to Dec. 2023 (MXN127,595 Mil) but then increased from Dec. 2023 (MXN127,595 Mil) to Dec. 2024 (MXN279,320 Mil).

Novartis AG Beginning Cash Position Historical Data

The historical data trend for Novartis AG's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novartis AG Beginning Cash Position Chart

Novartis AG Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Beginning Cash Position

Get a 7-Day Free Trial

221,039.90

198,124.21

241,886.87

127,595.42

279,320.39

Novartis AG Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Beginning Cash Position	Get a 7-Day Free Trial															222,273.64	173,473.06	155,612.44	283,825.22	234,430.51

Novartis AG Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

Novartis AG Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Novartis AG's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Novartis AG Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Novartis AG (MEX:NVS N) » Definitions » Beginning Cash Position

Comparable Companies

Traded in Other Exchanges

NVSEF:USA NVS:USA NOVN:Mexico NOVNz:UK 0K9E:UK 0QLR:UK NOTA:Germany NOVNEE:Switzerland NOVN:Switzerland NVS:Canada N1VS34:Brazil NVS:Argentina

Address

Lichtstrasse 35, Basel, CHE, 4056

Website

https://www.novartis.com

Novartis develops and manufactures innovative drugs. Key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States comprising close to one third of total revenue.

Novartis AG Headlines

No Headlines